Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring...
Rancho BioSciences·
Data Curation and Management
Single-cell
AI in Drug Discovery
Multi-omics
Press Release
New
Rancho BioSciences today formally announced the appointment of Amar Thyagarajan, PhD, as Chief Commercial Officer. Dr. Thyagarajan, who joined Rancho...
Rancho BioSciences·
Digital Pathology
AI in Drug Discovery
Precision Medicine
In today’s rapidly evolving scientific landscape, data has emerged as the cornerstone of discovery and innovation across life sciences. Organizations...
Rancho BioSciences today announced the appointment of Chris O’Brien as Chief Executive Officer. O’Brien will lead the company’s next phase of growth...
The exponential growth of biological and biomedical data in recent years has created both unprecedented opportunities and significant challenges for...
In the realm of life sciences, data plays a crucial role in advancing research, developing therapeutics, and ensuring regulatory compliance. However,...
Rancho BioSciences·
AI Solutions and Augmentation
Bioinformatics & Data Science
Data Mining
Exciting News from Rancho BioSciences! We’re thrilled to announce our participation at The 19th Annual Huntington’s Disease Therapeutics Conference!...
.svg){kind=small}
.jpg)
